Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Benkert

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Dementia (Basel, Switzerland)|March 1, 1995
Visual memory in Alzheimer patients: effects of practice, retention interval and severity of cognitive declineR Heun, J Bierbrauer, O Benkert
Neuropsychobiology|January 1, 1994
Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal menA Steiger, O Benkert, F Holsboer
Zahn-, Mund-, Und Kieferheilkunde Mit Zentralblatt|January 1, 1986
[Etiology and classification of intrapulpar dentinogenesis. A histopathological study of healthy teeth]R Beer, P Gängler, O Benkert
Psychopharmacologia|January 1, 1972
Effect of L-dopa on sexually impotent patientsO Benkert, G Crombach, G Kockott
Neuropharmacology|March 1, 1973
Dopamine, noradrenaline and 5-hydroxy-trytamine in relation to motor activity, fighting and mounting behaviour. II. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602 and parachlorophenylalanineO Benkert, A Renz, N Matussek
Pharmacopsychiatry|February 1, 1987
Clinical and neuroendocrine effects of zotepine--a new neuroleptic drugU von Bardeleben, O Benkert, F Holsboer
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
Dopamine agonists in schizophrenia: a reviewO Benkert, F Müller-Siecheneder, H Wetzel
International Clinical Psychopharmacology|August 15, 2002
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysisM J Müller, H Wetzel, O Benkert
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
The cardiac anxiety syndrome--a subtype of panic attacksW Maier, R Buller, H Rieger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1993
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controlsA Steiger, A Gerken, O Benkert, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Dementia (Basel, Switzerland)|March 1, 1995
Visual memory in Alzheimer patients: effects of practice, retention interval and severity of cognitive declineR Heun, J Bierbrauer, O Benkert
Neuropsychobiology|January 1, 1994
Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal menA Steiger, O Benkert, F Holsboer
Zahn-, Mund-, Und Kieferheilkunde Mit Zentralblatt|January 1, 1986
[Etiology and classification of intrapulpar dentinogenesis. A histopathological study of healthy teeth]R Beer, P Gängler, O Benkert
Psychopharmacologia|January 1, 1972
Effect of L-dopa on sexually impotent patientsO Benkert, G Crombach, G Kockott
Neuropharmacology|March 1, 1973
Dopamine, noradrenaline and 5-hydroxy-trytamine in relation to motor activity, fighting and mounting behaviour. II. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602 and parachlorophenylalanineO Benkert, A Renz, N Matussek
Pharmacopsychiatry|February 1, 1987
Clinical and neuroendocrine effects of zotepine--a new neuroleptic drugU von Bardeleben, O Benkert, F Holsboer
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
Dopamine agonists in schizophrenia: a reviewO Benkert, F Müller-Siecheneder, H Wetzel
International Clinical Psychopharmacology|August 15, 2002
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysisM J Müller, H Wetzel, O Benkert
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
The cardiac anxiety syndrome--a subtype of panic attacksW Maier, R Buller, H Rieger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1993
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controlsA Steiger, A Gerken, O Benkert, et al.
Pageof 18